| Literature DB >> 27096103 |
Katharina Feil1, Nicolina Boettcher2, Franziska Lezius3, Maximilian Habs1, Tobias Hoegen4, Katrin Huettemann4, Carolin Muth2, Ozan Eren2, Florian Schoeberl1, Andreas Zwergal1, Otmar Bayer2, Michael Strupp1.
Abstract
OBJECTIVE: Additionally to the forearm rolling test to detect mild unilateral upper limb dysfunction, the bed cycling test (BCT) for detection of mild to moderate lower limb dysfunction was developed, evaluated and compared to the leg holding test.Entities:
Keywords: Cerebrovascular disease/Stroke; clinical neurology; clinical neurology examination
Mesh:
Year: 2016 PMID: 27096103 PMCID: PMC4829574 DOI: 10.1002/brb3.445
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Figure 1Example of a patient performing the bed cycling test (BCT) (patient no. 5). Patient is lying on his back. Both legs are flexed in the hip. The patient is asked to air cycle rapidly with eyes closed forwards for 10 sec and backwards for 10 sec (so called “bed cycling”).
Compilation of rating videos for analysis
| Rating video no. 1 | Rating video no. 2 | Rating video no. 3 | |
|---|---|---|---|
| BCT | Group 1 | Group 2 | Group 3 |
| LHT | Group 2 | Group 3 | Group 1 |
| BCT + LHT | Group 3 | Group 1 | Group 2 |
BCT, bed cycling test; LHT, leg holding test in supine position.
Summary of clinical data of patients
| Clinical data of patients | Total number of patients |
|---|---|
| Etiology | |
| Ischemia | 56 |
| Hemorrhage | 3 |
| Tumor | 1 |
| Lesion location | |
| MCA | 43 |
| ACA | 3 |
| PCA | 2 |
| Mesencephalon | 5 |
| Pons | 5 |
| Medulla oblongata | 1 |
| Side of lesion | |
| Left | 24 |
| Right | 36 |
| Onset of symptoms | |
| Up to 72 h | 29 |
| 72 h up to 3 months | 24 |
| More than 3 months | 7 |
| Graduation of paresis (muscle strength grade) | |
| 3/5 | 10 |
| 4/5 | 50 |
| Leg holding test in supine position | |
| Pathological | 38 (17 left/21 right) |
| Not pathological | 20 |
| Both sides/not evaluable | 0 |
| Bed cycling test forwards | |
| Pathological | 57 (31 left/26 right) |
| Not pathological | 3 |
| Both sides/not evaluable | 0 |
| Bed cycling test backwards | |
| Pathological | 56 (32 left/24 right) |
| Not pathological | 2 |
| Both sides/not evaluable | 0 |
| Heel‐knee test | |
| Pathological | 39 (19 left/20 right) |
| Not pathological | 15 |
| Both sides/not evaluable | 0 |
| 5‐m walk | |
| Pathological | 36 |
| Not pathological | 9 |
| Both sides/not evaluable | 15 (not feasible/patient not able to walk) |
| Muscle tone lower limb | |
| Pathological | 5 (1 left/4 right) |
| Not pathological | 54 |
| Both sides/not evaluable | 0 |
| Reflexes | |
| Pathological | 6 |
| Not pathological | 54 |
| Both sides/not evaluable | 0 |
| Babinksi's sign | |
| Pathological | 16 (8 left/8 right) |
| Not pathological | 44 |
| Both sides/not evaluable | 0 |
| Sensibility | |
| Pathological | 14 |
| Not pathological | 46 |
| Both sides/not evaluable | 0 |
MCA, mid cerebral artery; ACA, anterior cerebral artery; PCA, posterior cerebral artery.
Clinical data of patients
| Patient no. | Age | Sex | Onset of symptoms | Etiology | Lesion location | Side of lesion | Graduation of paresis | LHT | BCT forwards | BCT backwards | Babinski sign | 5‐m walk | Sensibility | Reflexes | Heel‐knee test |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 81 | Male | 72 ho up to 3 months | 1 | 1 | Right | 4 | + left | + left | + left | − | + | − | − | + left |
| 2 | 55 | Male | Up to 72 h | 1 | 1 | Right | 3 | + left | + left | + left | + left | Not feasible | + | + | + left |
| 3 | 73 | Female | Up to 72 h | 1 | 1 | Left | 3 | + right | + right | + right | + right | + | − | − | + right |
| 4 | 82 | Female | Up to 72 h | 1 | 1 | Right | 4 | + left | + left | + left | − | + | − | − | + left |
| 5 | 82 | Male | Up to 72 h | 1 | 1 | Left | 4 | − | − | + right | − | − | − | − | + right |
| 6 | 92 | Female | 72 h up to 3 months | 1 | 1 | Right | 4 | + left | + left | + left | + left | + | − | − | + left |
| 7 | 73 | Female | 72 h up to 3 months | 1 | 1 | Right | 3 | −/+ both | + left | + left | + left | Not feasible | + | + | Not feasible |
| 8 | 66 | Female | 72 h up to 3 months | 1 | 1 | Right | 4 | + left | + left | + left | − | + | + | − | + left |
| 9 | 54 | Female | 72 h up to 3 months | 1 | 1 | Left | 4 | + right | + right | + right | − | + | − | − | − |
| 10 | 78 | Female | 72 h up to 3 months | 2 | 4 | Right | 3 | + left | + left | + left | − | Not feasible | − | − | Not feasible |
| 11 | 62 | Male | 72 h up to 3 months | 1 | 1 | Right | 4 | + left | + left | + left | − | + | − | − | + left |
| 12 | 79 | Female | 72 h up to 3 months | 1 | 5 | Right | 4 | + right | + right | + right | − | + | + | − | + right |
| 13 | 71 | Male | 72 h up to 3 months | 1 | 1 | Left | 4 | − | + right | + right | + right | + | − | − | + right |
| 14 | 47 | Male | Up to 72 h | 1 | 1 | Left | 4 | − | + right | + right | + right | − | − | − | + right |
| 15 | 55 | Male | 72 h up to 3 months | 1 | 5 | Left | 4 | + right | + right | + right | + right | + | + | − | + right |
| 16 | 86 | Female | Up to 72 h | 1 | 1 | Left | 4 | + right | + right | + right | − | + | − | − | + right |
| 17 | 78 | Female | 72 h up to 3 months | 1 | 1 | Right | 4 | + left | + left | + left | − | + | − | − | − |
| 18 | 62 | Male | 72 h up to 3 months | 2 | 1 | Left | 3 | + right | + right | + right | − | Not feasible | − | − | + right |
| 19 | 72 | Female | 72 h up to 3 months | 1 | 1 | Left | 4 | + right | + right | + right | + right | + | − | − | − |
| 20 | 87 | Female | 72 h up to 3 months | 1 | 1 | Right | 4 | + left | + left | + left | −− | + | − | − | − |
| 21 | 52 | Male | Up to 72 h | 2 | 4 | Right | 4 | + left | + left | + left | − | Not feasible | + | + | + left |
| 22 | 38 | Male | 72 h up to 3 months | 1 | 1 | Right | 4 | − | + left | + left | + left | − | − | − | + left |
| 23 | 69 | Male | 72 h up to 3 months | 1 | 3 | Right | 4 | − | − | + left | − | − | − | − | − |
| 24 | 54 | Male | 72 h up to 3 months | 1 | 5 | Left | 4 | + right | + right | + right | + right | + | − | − | + right |
| 25 | 68 | Male | Up to 72 h | 1 | 1 | Left | 4 | + right | + right | + right | + right | + | − | − | + right |
| 26 | 78 | Female | Up to 72 h | 1 | 1 | Left | 4 | + right | + right | + right | − | + | − | − | + right |
| 27 | 73 | Female | 72 h up to 3 months | 1 | 1 | Right | 3 | + left | + left | + left | − | + | − | − | + left |
| 28 | 80 | Female | 72 h up to 3 months | 1 | 1 | Left | 4 | + right | + right | + right | − | + | − | − | + right |
| 29 | 92 | Male | Up to 72 h | 1 | 1 | Right | 3 | − | + left | + left | − | + | + | − | + left |
| 30 | 81 | Male | 72 h up to 3 months | 1 | 4 | Left | 4 | + right | + right | + right | − | Not feasible | − | − | + right |
| 31 | 34 | Female | More than 3 months | 1 | 6 | Right | 4 | + right | + right | − | − | − | + | − | − |
| 32 | 68 | Female | Up to 72 h | 1 | 1 | Left | 4 | + right | + right | − | − | Not feasible | − | − | Not feasible |
| 33 | 68 | Male | 72 h up to 3 months | 1 | 2 | Left | 4 | + right | + right | + right | − | + | − | − | + right |
| 34 | 74 | Male | More than 3 months | 1 | 1 | Left | 4 | + right | + right | + right | − | + | − | + | + right |
| 35 | 80 | Female | 72 h up to 3 months | 1 | 1 | Right | 4 | − | + left | + left | − | + | − | − | + left |
| 36 | 93 | Male | Up to 72 h | 1 | 1 | Right | 4 | + left | + left | + left | + left | + | − | − | + left |
| 37 | 68 | Female | Up to 72 h | 1 | 2 | Left | 4 | + right | + right | −/+ both | − | Not feasible | − | − | − |
| 38 | 75 | Male | Up to 72 h | 1 | 1 | Right | 4 | − | + left | + left | − | − | − | − | − |
| 39 | 81 | Male | Up to 72 h | 1 | 1 | Right | 3 | − | + left | + left | + left | + | − | − | + left |
| 40 | 21 | Male | More than 3 months | 3 | 1 | Right | 4 | − | + left | + left | − | + | − | − | + left |
| 41 | 72 | Male | More than 3 months | 1 | 1 | Left | 4 | + right | + right | + right | − | + | + | + | + right |
| 42 | 64 | Female | Up to 72 h | 1 | 5 | Right | 4 | + left | + left | + left | − | Not feasible | + | − | + left |
| 43 | 67 | Male | Up to 72 h | 1 | 1 | Left | 3 | + right | + right | + right | − | Not feasible | − | − | + right |
| 44 | 43 | Female | 72 h up to 3 months | 1 | 1 | Right | 4 | − | + left | + left | − | − | − | − | − |
| 45 | 65 | Male | Up to 72 h | 1 | 1 | Right | 4 | + left | + left | + left | − | + | − | − | + left |
| 46 | 71 | Male | Up to 72 h | 1 | 2 | Right | 3 | + left | + left | + right | − | + | − | − | + right |
| 47 | 77 | Female | Up to 72 h | 1 | 1 | Right | 4 | − | + left | + left | − | + | + | − | + left |
| 48 | 62 | Male | Up to 72 h | 1 | 3 | Right | 4 | − | − | + left | − | + | − | − | − |
| 49 | 74 | Female | Up to 72 h | 1 | 1 | Right | 4 | − | + left | + left | − | + | − | − | − |
| 50 | 68 | Male | Up to 72 h | 1 | 1 | Left | 4 | + right | + right | + right | − | + | − | − | + right |
| 51 | 72 | Male | More than 3 months | 1 | 2 | Right | 4 | − | + left | + left | + left | + | − | − | + both |
| 52 | 57 | Female | Up to 72 h | 1 | 4 | Right | 4 | + right | + right | −/+ both | − | Not feasible | − | − | + right |
| 53 | 79 | Female | Up to 72 h | 1 | 4 | Right | 4 | − | + left | + left | − | Not feasible | − | − | + both |
| 54 | 73 | Male | Up to 72 h | 1 | 1 | Left | 4 | − | + right | + right | − | + | − | − | − |
| 55 | 60 | Male | More than 3 months | 1 | 1 | Left | 4 | − | + right | + right | − | + | − | − | − |
| 56 | 54 | Male | More than 3 months | 1 | 1 | Right | 4 | −/+ both | + left | + left | + right | Not feasible | − | − | + both |
| 57 | 67 | Male | Up to 72 h | 1 | 1 | Left | 4 | − | + right | + right | − | − | + | − | − |
| 58 | 73 | Male | Up to 72 h | 1 | 1 | Right | 4 | − | + left | + left | − | − | + | + | − |
| 59 | 80 | Female | Up to 72 h | 1 | 4 | Right | 4 | + left | + left | + left | + left | Not feasible | + | − | + left |
| 60 | 41 | Male | 72 h up to 3 months | 1 | 1 | Right | 4 | + left | + left | + left | − | Not feasible | − | − | + left |
Patient's characteristics, categorized by patient number, gender, age, onset of symptoms as well as etiology of symptoms, side of lesion. The graduation of paresis was performed using the oxford scale. According to Medical research council (MRC) scale (Palo Alto 1978; Paternostro‐Sluga et al. 2008). Muscle strength is graded 0 to 5 (3 = through full range actively against gravity, 4 = through full range actively against some resistance, 5 = through full range actively against strong resistance). + = pathological; − = not pathological/unremarkable. Etiology: 1 = ischemia, 2 = hemorrhage, 3 = tumor. Lesion location: 1 = supratentorial mid cerebral artery (MCA), 2 = supratentorial anterior cerebral artery (ACA), 3 = supratentorial posterior cerebral artery (PCA), 4 = infratentorial mesencephalon/midbrain, 5 = infratentorial pons/brainstem, 6 = infratentorial medulla oblongata/brainstem.
BCT, bed cycling test; LHT, leg holding test in supine position.
Detailed anatomical description of involved structures in patient group
| Patient no. | Age | Side of lesion | Graduation of paresis | Anatomical location of lesion |
|---|---|---|---|---|
| 1 | 81 | Right | 4 | Lateral lenticulostriate artery infarction |
| 2 | 55 | Right | 3 | Lateral lenticulostriate artery infarction |
| 3 | 73 | Left | 3 | Post‐ and subcentral media infarction including posterior insula |
| 4 | 82 | Right | 4 | Lateral lenticulostriate artery infarction |
| 5 | 82 | Left | 4 | Gyrus postcentralis |
| 6 | 92 | Right | 4 | Gyrus praecentralis/Sulcus centralis |
| 7 | 73 | Right | 3 | Medial and lateral lenticulostriate artery infarction |
| 8 | 66 | Right | 4 | Gyrus praecentralis and postcentralis |
| 9 | 54 | Left | 4 | Media infarction, superior division |
| 10 | 78 | Right | 3 | Basal ganglia hemorrhage |
| 11 | 62 | Right | 4 | Capsula externa and Nucleus caudatus right |
| 12 | 79 | Right | 4 | Paramedian pons infarction |
| 13 | 71 | Left | 4 | Putamen and posterior insular region |
| 14 | 47 | Left | 4 | Corpus ncl. Caudatus |
| 15 | 55 | Left | 4 | Paramedian ponst infarction |
| 16 | 86 | Left | 4 | Posterioren Gyrus frontalis medius, Gyrus praecentralis and postcentralis |
| 17 | 78 | Right | 4 | Lateral lenticulostriate artery infarction |
| 18 | 62 | Left | 3 | Hemorrhage capsula interna (thalamus/crus posterior) |
| 19 | 72 | Left | 4 | Corona radiata parietal, temporal (multiple, embolic) |
| 20 | 87 | Right | 4 | Cortical border zone infarction between MCA und PCA |
| 21 | 52 | Right | 4 | Basal ganglia hemorrhage |
| 22 | 38 | Right | 4 | 2/3 MCA territory infarction frontal, temporal, insular region and putamen (dorsolateral) |
| 23 | 69 | Right | 4 | Posterior infarction |
| 24 | 54 | Left | 4 | Paramedian pons infarction |
| 25 | 68 | Left | 4 | Infarction of Capsula interna (Crus posterior) |
| 26 | 78 | Left | 4 | Capsula externa, posterior insula |
| 27 | 73 | Right | 3 | Anterior Choroideal artery |
| 28 | 80 | Left | 4 | Anterior Choroideal artery |
| 29 | 92 | Right | 3 | Lateral lenticulostriate artery infarction |
| 30 | 81 | Left | 4 | Thalamus |
| 31 | 34 | Right | 4 | Medulla oblongata (dorsolateral) |
| 32 | 68 | Left | 4 | MCA‐territory (posterior division) |
| 33 | 68 | Left | 4 | ACA‐infarction |
| 34 | 74 | Left | 4 | Capsula interna |
| 35 | 80 | Right | 4 | Lobus temporalis, basal ganglia, Cortical (MCA territory) |
| 36 | 93 | Right | 4 | MCA territory, pericentral region, cortical border zone (multiple, embolic) |
| 37 | 68 | Left | 4 | ACA‐infarction |
| 38 | 75 | Right | 4 | Corona radiata |
| 39 | 81 | Right | 3 | Putaman dorsal and posterior insular region |
| 40 | 21 | Right | 4 | Resection of a meduloblastoma occipital |
| 41 | 72 | Left | 4 | Basal ganglia |
| 42 | 64 | Right | 4 | Pons infarction anterolateral |
| 43 | 67 | Left | 3 | MCA territory (multiple, embolic) |
| 44 | 43 | Right | 4 | Cortical border zone infarction |
| 45 | 65 | Right | 4 | Cortical border zone infarction |
| 46 | 71 | Right | 3 | ACA‐infarction right and PICA |
| 47 | 77 | Right | 4 | Lacunar infarction basal ganglia |
| 48 | 62 | Right | 4 | Thalamus medial (PCA territory, multiple embolic) |
| 49 | 74 | Right | 4 | MCA territory, Gyrus praecentralis, insular region posterior (multiple, embolic) |
| 50 | 68 | Left | 4 | Lateral lenticulostriate artery infarction (multiple, embolic) |
| 51 | 72 | Right | 4 | Lacunar infarction white matter media territory |
| 52 | 57 | Right | 4 | Paramedian pons infarction |
| 53 | 79 | Right | 4 | Basal ganglia |
| 54 | 73 | Left | 4 | MCA territory (posterior insular region, basal ganglia, multiple, embolic) |
| 55 | 60 | Left | 4 | Capsula interna |
| 56 | 54 | Right | 4 | Lateral and medial lenticulostriate artery infarction (basal ganglia) |
| 57 | 67 | Left | 4 | Cortical border infarction |
| 58 | 73 | Right | 4 | Gyrus praecentralis (multiple embolic) |
| 59 | 80 | Right | 4 | Thalamus dorsolateral |
| 60 | 41 | Right | 4 | MCA territory (Gyrus praecentralis, postcentralis, Lobus parietalis super, insular region, operculum frontal and temporal, corpus caudatus) |
MCA, mid cerebral artery; ACA, anterior cerebral artery; PCA, posterior cerebral artery.
Test properties of bed cycling test, leg holding test and performing both clinical tests together. Values are expressed as mean and 95% confidence interval (range)
| BCT | Leg holding test | Both clinical tests | |
|---|---|---|---|
| Sensitivity | 0.64 (0.57–0.71) | 0.42 (0.38–0.54) | 0.68 (0.61–0.75) |
| Specificity | 0.70 (0.63–0.77) | 0.85 (0.80–0.90) | 0.78 (0.72–0.84) |
| PPV | 0.68 (0.60–0.74) | 0.76 (0.67–0.84) | 0.76 (0.69–0.82) |
| NPV | 0.67 (0.60–0.74) | 0.62 (0.57–0.68) | 0.72 (0.65–0.78) |
BCT: bed cycling test; PPV: positive predictive value; NPV: negative predictive value.